rivastigmine has been researched along with Dermatitis Medicamentosa in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dautzenberg, PJ; Golüke, NM; Jessurun, N; Keijsers, CJ; van Strien, AM | 1 |
| Alva, G; Cummings, JL; Galvin, JE; Meng, X; Velting, DM | 1 |
| Allain-Veyrac, G; Collonnier, C; Jolliet, P; Lebreton, A | 1 |
| Cytryn, E; Segers, K; Surquin, M | 1 |
| Andreasen, N; Cummings, J; Grossberg, G; Lane, R; Nagel, J; Onofrj, M; Sadowsky, C; Winblad, B; Zechner, S | 1 |
1 review(s) available for rivastigmine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
Topics: Aged, 80 and over; Buttocks; Cholinesterase Inhibitors; Dementia; Dermatitis, Allergic Contact; Drug Eruptions; Exanthema; Humans; Intertrigo; Male; Phenylcarbamates; Rivastigmine; Syndrome | 2011 |
1 trial(s) available for rivastigmine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Capsules; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Female; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2007 |
4 other study(ies) available for rivastigmine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Skin lesions after oral acetylcholinesterase inhibitor therapy: a case report.
Topics: Administration, Oral; Aged; Cholinesterase Inhibitors; Drug Eruptions; Galantamine; Humans; Male; Phenylcarbamates; Rivastigmine; Transdermal Patch | 2014 |
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.
Topics: Administration, Cutaneous; Aged; Alzheimer Disease; Dose-Response Relationship, Drug; Drug Eruptions; Female; Humans; Incidence; Male; Neuroprotective Agents; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index; Transdermal Patch | 2015 |
Do local meteorological conditions influence skin irritation caused by transdermal rivastigmine? A retroprospective, pilot study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Belgium; Cholinesterase Inhibitors; Delirium; Drug Eruptions; Female; Hospitals, University; Humans; Incidence; Male; Medical Records; Middle Aged; Nootropic Agents; Outpatient Clinics, Hospital; Phenylcarbamates; Pilot Projects; Retrospective Studies; Rivastigmine; Sweating; Transdermal Patch; Weather | 2012 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capecitabine; Carbamates; Ceftriaxone; Clonidine; Deoxycytidine; Diagnosis, Differential; Drug Eruptions; Ethacridine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Indapamide; Isotretinoin; Isoxazoles; Leflunomide; Male; Middle Aged; Nelfinavir; Phenylcarbamates; Rivastigmine; Salicylates; Severity of Illness Index; Sulfonamides; Thiophenes | 2002 |